DELMAR PHARMACEUTICALS INC (DMPI)
Institutional ownership reported to the SEC as of Q2 2020, across 7 quarters.
8
Reporting holders
$189.6K
Reported value
0.0%
Held as options
+3
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $63.0K | 91,110 | 0.00% | 3q | +663.1%+$54.7K |
| Virtu Financial LLC | $47.0K | 68,359 | 0.01% | 2q | +3.5%+$1.6K |
| BARCLAYS PLC | $25.0K | 36,500 | 0.00% | 3q | -59.2%-$36.3K |
| BREWIN DOLPHIN LTD | $20.6K | 30,000 | 0.00% | 3q | HELD |
| CITADEL ADVISORS LLC | $16.0K | 23,107 | 0.00% | new | NEW |
| NORTHERN TRUST CORP | $9.0K | 12,441 | 0.00% | new | NEW |
| UBS Group AG | $6.0K | 8,045 | 0.00% | new | NEW |
| ADVISOR GROUP HOLDINGS, INC. | $3.0K | 4,000 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2020 | 8 | $189.6K | 273,562 | 3 | 2 | 1 | 0.0% |
| Q1 2020 | 5 | $71.9K | 180,439 | 1 | 0 | 1 | 0.0% |
| Q4 2019 | 8 | $337.7K | 1,494,048 | 6 | 1 | 0 | 0.0% |
| Q3 2019 | 4 | $650.0K | 1,177,565 | 3 | 0 | 0 | 0.0% |
| Q2 2019 | 4 | $89.0K | 68,790 | 4 | 0 | 0 | 0.0% |
| Q1 2019 | 11 | $391.0K | 800,006 | 1 | 2 | 4 | 0.0% |
| Q4 2018 | 11 | $682.0K | 1,985,803 | 2 | 0 | 0 | 0.0% |